Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
[6,6-2H2]-glucose is a nonradioactive, stable isotope-labeled form of glucose used as a metabolic tracer in clinical research. It contains two deuterium atoms at the 6-position of the glucose molecule. When administered intravenously, it labels the blood glucose pool and is subsequently incorporated into the DNA of dividing cells, such as T cells, B cells, and NK cells, during de novo purine and pyrimidine synthesis. This incorporation allows for the quantification of cell proliferation and disappearance kinetics using mass spectrometry. It is primarily utilized in exploratory clinical studies, such as those conducted by the Academisch Medisch Centrum, to measure lymphocyte turnover and immune reconstitution kinetics in patients following hematopoietic stem cell transplantation (HSCT).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on [6,6-2H2]-glucose.